Alex is Cinven’s Chief Operating Officer, responsible for operational aspects of the business including business development and strategy.  

Previously, Alex was Head of Cinven North America between 2016 and 2022 and a member of the Healthcare Sector team. 

He has been involved in a number of transactions, including BioAgilytix, Clario (formerly Bioclinica), Jaggaer, LGC, Medpace, National Seating & Mobility, Synlab and Taxwell (formerly Drake Software). 

Prior to this, he worked in the Investment Banking Division of Morgan Stanley in London. 

Alex has an MA in History from Edinburgh University.  

Alex joined Cinven in 2006.